$ADNT Cashflow Statement | Understand Stock

$ADNT

$16.67 +$0.06 (0.36%) Pre-market

$ADNT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Operating Activities
Net income (loss) attributable to Adient
Income attributable to noncontrolling interests
Net income (loss)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation
Amortization of intangibles
Pension benefit expense
Pension contributions, net
Equity in earnings of partially-owned affiliates, net of dividends received
(Gain) on sale of / impairment of nonconsolidated partially-owned affiliates
Premium and transaction costs paid on repurchase of debt
Premium paid on repurchase of debt
Retrospective recoveries of Brazil indirect tax credits
Derivative loss on the 2021 Yanfeng Transaction
Deferred income taxes
Loss (gain) on divestitures - net
Non-cash impairment charges
Equity-based compensation
Other
Changes in assets and liabilities:
Receivables
Inventories
Other assets
Restructuring reserves
Accounts payable and accrued liabilities
Accrued income taxes

Cash provided (used) by operating activities
Investing Activities
Capital expenditures
Sale of property, plant and equipment
Settlement of derivative contracts
Acquisition of businesses, net of cash acquired
Business divestitures
Changes in long-term investments
Loans to affiliates
Other
Cash provided (used) by investing activities

Financing Activities
Increase (decrease) in short-term debt
Increase (decrease) in long-term debt
Repayment of long-term debt
Debt financing costs
Cash dividends
Share repurchases
Cash paid to acquire a noncontrolling interest
Dividends paid to noncontrolling interests
Formation of consolidated joint venture
Other
Cash provided (used) by financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale
Less: cash classified within current assets held for sale
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments